These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 87558)

  • 21. [Pharma-clinics. Drug of the month. Polyvalent antipneumococcal vaccine (Pneumune)].
    Scheen AJ
    Rev Med Liege; 1996 Mar; 51(3):257-8. PubMed ID: 8668891
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
    Austrian R
    J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides: follow-up immunization with pneumococcal polysaccharides.
    Gigliotti F
    Pediatr Infect Dis J; 1988 Aug; 7(8):604. PubMed ID: 3174304
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
    Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal antibodies measured with a rapid enzyme-linked-immunosorbent assay (ELISA), using the whole vaccine as antigen. Suggestions for clinical application.
    Snijder JA; Löwenberg A; Klompmaker I; Weits J
    Neth J Med; 1988 Aug; 33(1-2):52-9. PubMed ID: 3247011
    [No Abstract]   [Full Text] [Related]  

  • 27. Capsular polysaccharides as human vaccines.
    Jennings HJ
    Adv Carbohydr Chem Biochem; 1983; 41():155-208. PubMed ID: 6195893
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumococcal vaccines in adults: assessing the evolving evidence.
    Grabenstein JD; Manoff SB
    Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection against infections with Streptococcus pneumoniae and Haemophilus influenzae type B in a population of splenectomized individuals with varying vaccination status.
    Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB
    Adv Exp Med Biol; 1997; 418():833-5. PubMed ID: 9331782
    [No Abstract]   [Full Text] [Related]  

  • 30. [New vaccines].
    Ozişik A; Ustaçelebi S
    Mikrobiyol Bul; 1992 Jan; 26(1):82-9. PubMed ID: 1574025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal conjugate vaccines.
    Eskola J; Anttila M
    Pediatr Infect Dis J; 1999 Jun; 18(6):543-51. PubMed ID: 10391188
    [No Abstract]   [Full Text] [Related]  

  • 32. New challenges in the development of a conjugate pneumococcal vaccine.
    Baltimore RS
    JAMA; 1992 Dec; 268(23):3366-7. PubMed ID: 1453531
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemophilus type b polysaccharide vaccine. Committee on Infectious Diseases.
    Pediatrics; 1985 Aug; 76(2):322-4. PubMed ID: 3875076
    [No Abstract]   [Full Text] [Related]  

  • 35. New bacterial vaccines.
    Mäkelä PH
    Pediatr Infect Dis; 1982; 1(5):291-4. PubMed ID: 6818533
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia.
    Chintu C; Gupta K; Osborne C; Masona JM
    Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumococcal vaccination].
    Léophonte P
    Rev Mal Respir; 1999 Nov; 16(5):763-6. PubMed ID: 10612144
    [No Abstract]   [Full Text] [Related]  

  • 39. Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes.
    Friedman EA; Beyer MM; Hirsch SR; Schiffman G
    JAMA; 1980 Nov; 244(20):2310-1. PubMed ID: 7431555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
    Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
    Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.